Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | MCOLN2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MCOLN2 mRNA | CTD | PMID:22079256 | 1,2-dichloroethane | increases expression | ISO | Mcoln2 (Mus musculus) | 6480464 | ethylene dichloride results in increased expression of MCOLN2 mRNA | CTD | PMID:28960355 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of MCOLN2 mRNA | CTD | PMID:32741896 | 17beta-estradiol | increases expression | ISO | MCOLN2 (Homo sapiens) | 6480464 | Estradiol results in increased expression of MCOLN2 mRNA | CTD | PMID:31614463 | 17beta-estradiol 3-benzoate | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of MCOLN2 mRNA | CTD | PMID:32741896 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Mcoln2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of MCOLN2 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of MCOLN2 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | MCOLN2 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MCOLN2 mRNA | CTD | PMID:22903824 | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:32109520 | 4,4'-diaminodiphenylmethane | increases expression | EXP | | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of MCOLN2 mRNA | CTD | PMID:30723492 | 4-hydroxyphenyl retinamide | increases expression | ISO | Mcoln2 (Mus musculus) | 6480464 | Fenretinide results in increased expression of MCOLN2 mRNA | CTD | PMID:28973697 | 5-aza-2'-deoxycytidine | affects expression | ISO | MCOLN2 (Homo sapiens) | 6480464 | Decitabine affects the expression of MCOLN2 mRNA | CTD | PMID:23300844 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of MCOLN2 mRNA | CTD | PMID:31881176 | aflatoxin B1 | decreases methylation | ISO | MCOLN2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of MCOLN2 intron | CTD | PMID:30157460 | antirheumatic drug | decreases expression | ISO | MCOLN2 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of MCOLN2 mRNA | CTD | PMID:24449571 | arsenite(3-) | decreases expression | ISO | Mcoln2 (Mus musculus) | 6480464 | arsenite results in decreased expression of MCOLN2 mRNA | CTD | PMID:18191166 | benzo[a]pyrene | affects methylation | ISO | MCOLN2 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of MCOLN2 intron and Benzo(a)pyrene affects the methylation of MCOLN2 promoter | CTD | PMID:27901495 and PMID:30157460 | benzo[a]pyrene | increases methylation | ISO | MCOLN2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of MCOLN2 exon | CTD | PMID:27901495 | benzo[b]fluoranthene | increases expression | ISO | Mcoln2 (Mus musculus) | 6480464 | benzo(b)fluoranthene results in increased expression of MCOLN2 mRNA | CTD | PMID:26377693 | benzo[e]pyrene | decreases methylation | ISO | MCOLN2 (Homo sapiens) | 6480464 | benzo(e)pyrene results in decreased methylation of MCOLN2 intron | CTD | PMID:30157460 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of MCOLN2 mRNA | CTD | PMID:25181051 more ... | bromobenzene | increases expression | EXP | | 6480464 | bromobenzene results in increased expression of MCOLN2 mRNA | CTD | PMID:32479839 | buta-1,3-diene | decreases expression | ISO | Mcoln2 (Mus musculus) | 6480464 | 1 and 3-butadiene results in decreased expression of MCOLN2 mRNA | CTD | PMID:29038090 | cadmium dichloride | increases methylation | EXP | | 6480464 | Cadmium Chloride results in increased methylation of MCOLN2 promoter | CTD | PMID:22457795 | carbon nanotube | increases expression | ISO | Mcoln2 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | chlordecone | increases expression | ISO | Mcoln2 (Mus musculus) | 6480464 | Chlordecone results in increased expression of MCOLN2 mRNA | CTD | PMID:33711761 | choline | multiple interactions | ISO | Mcoln2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MCOLN2 mRNA | CTD | PMID:20938992 | chromium(6+) | affects expression | ISO | MCOLN2 (Homo sapiens) | 6480464 | chromium hexavalent ion affects the expression of MCOLN2 mRNA | CTD | PMID:30690063 | cisplatin | affects expression | ISO | MCOLN2 (Homo sapiens) | 6480464 | Cisplatin affects the expression of MCOLN2 mRNA | CTD | PMID:23300844 | cisplatin | increases expression | ISO | MCOLN2 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of MCOLN2 mRNA | CTD | PMID:27392435 | clodronic acid | decreases expression | ISO | MCOLN2 (Homo sapiens) | 6480464 | Clodronic Acid results in decreased expression of MCOLN2 mRNA | CTD | PMID:25596134 | dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of MCOLN2 mRNA | CTD | PMID:20032058 | dexamethasone | multiple interactions | EXP | | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in decreased expression of MCOLN2 mRNA] | CTD | PMID:20032058 | dieldrin | affects response to substance | ISO | MCOLN2 (Homo sapiens) | 6480464 | MCOLN2 gene SNP affects the susceptibility to Dieldrin | CTD | PMID:25622337 | dioxygen | decreases expression | ISO | MCOLN2 (Homo sapiens) | 6480464 | Oxygen deficiency results in decreased expression of MCOLN2 mRNA | CTD | PMID:25596134 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of MCOLN2 mRNA | CTD | PMID:29391264 | folic acid | multiple interactions | ISO | Mcoln2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MCOLN2 mRNA | CTD | PMID:20938992 | FR900359 | increases phosphorylation | ISO | MCOLN2 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of MCOLN2 protein | CTD | PMID:37730182 | genistein | decreases expression | ISO | Mcoln2 (Mus musculus) | 6480464 | Genistein results in decreased expression of MCOLN2 mRNA | CTD | PMID:32186404 | L-methionine | multiple interactions | ISO | Mcoln2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MCOLN2 mRNA | CTD | PMID:20938992 | lipopolysaccharide | multiple interactions | ISO | MCOLN2 (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | lipopolysaccharide | increases expression | ISO | MCOLN2 (Homo sapiens) | 6480464 | Lipopolysaccharides results in increased expression of MCOLN2 mRNA | CTD | PMID:35811015 | methapyrilene | decreases methylation | ISO | MCOLN2 (Homo sapiens) | 6480464 | Methapyrilene results in decreased methylation of MCOLN2 intron | CTD | PMID:30157460 | methcathinone | increases expression | ISO | MCOLN2 (Homo sapiens) | 6480464 | monomethylpropion results in increased expression of MCOLN2 mRNA | CTD | PMID:22303338 | methyl methanesulfonate | decreases expression | ISO | MCOLN2 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of MCOLN2 mRNA | CTD | PMID:23649840 | nickel sulfate | increases expression | ISO | MCOLN2 (Homo sapiens) | 6480464 | nickel sulfate results in increased expression of MCOLN2 mRNA | CTD | PMID:22714537 | perfluorohexanesulfonic acid | increases expression | ISO | Mcoln2 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of MCOLN2 mRNA | CTD | PMID:37995155 | perfluorooctane-1-sulfonic acid | affects expression | ISO | Mcoln2 (Mus musculus) | 6480464 | perfluorooctane sulfonic acid affects the expression of MCOLN2 mRNA | CTD | PMID:19429403 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Mcoln2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of MCOLN2 mRNA | CTD | PMID:36331819 | perfluorooctanoic acid | affects expression | ISO | Mcoln2 (Mus musculus) | 6480464 | perfluorooctanoic acid affects the expression of MCOLN2 mRNA | CTD | PMID:19429403 | pirinixic acid | increases expression | ISO | Mcoln2 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of MCOLN2 mRNA | CTD | PMID:20813756 | pirinixic acid | decreases expression | ISO | Mcoln2 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of MCOLN2 mRNA | CTD | PMID:17426115 | potassium chromate | decreases expression | ISO | MCOLN2 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of MCOLN2 mRNA | CTD | PMID:22079256 | potassium chromate | increases expression | ISO | MCOLN2 (Homo sapiens) | 6480464 | potassium chromate(VI) results in increased expression of MCOLN2 mRNA | CTD | PMID:22714537 | potassium chromate | multiple interactions | ISO | MCOLN2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MCOLN2 mRNA | CTD | PMID:22079256 | protein kinase inhibitor | multiple interactions | ISO | MCOLN2 (Homo sapiens) | 6480464 | Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of MCOLN2 mRNA] | CTD | PMID:28003376 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | MCOLN2 (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | silicon dioxide | increases expression | ISO | Mcoln2 (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of MCOLN2 mRNA | CTD | PMID:29203145 and PMID:29341224 | sodium arsenite | increases expression | ISO | MCOLN2 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of MCOLN2 mRNA | CTD | PMID:22714537 | sodium arsenite | decreases expression | ISO | Mcoln2 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of MCOLN2 mRNA | CTD | PMID:37682722 | succimer | multiple interactions | ISO | Mcoln2 (Mus musculus) | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MCOLN2 mRNA | CTD | PMID:21641980 | sulforaphane | decreases expression | ISO | MCOLN2 (Homo sapiens) | 6480464 | sulforaphane results in decreased expression of MCOLN2 mRNA | CTD | PMID:26833863 | temozolomide | increases expression | ISO | MCOLN2 (Homo sapiens) | 6480464 | Temozolomide results in increased expression of MCOLN2 mRNA | CTD | PMID:31758290 | testosterone | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of MCOLN2 mRNA and Testosterone inhibits the reaction [Dexamethasone results in decreased expression of MCOLN2 mRNA] | CTD | PMID:20032058 and PMID:32741896 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of MCOLN2 mRNA | CTD | PMID:31150632 | titanium dioxide | affects expression | ISO | Mcoln2 (Mus musculus) | 6480464 | titanium dioxide affects the expression of MCOLN2 mRNA | CTD | PMID:17656681 | valproic acid | increases expression | ISO | MCOLN2 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of MCOLN2 mRNA | CTD | PMID:23179753 more ... | vincristine | increases expression | ISO | MCOLN2 (Homo sapiens) | 6480464 | Vincristine results in increased expression of MCOLN2 mRNA | CTD | PMID:23649840 | |